ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ImpediMed Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Total Liabilities & Equity
AU$47m
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
12%
R
Respiri Ltd
ASX:RSH
Total Liabilities & Equity
AU$6.2m
CAGR 3-Years
-12%
CAGR 5-Years
44%
CAGR 10-Years
-5%
C
Cyclopharm Ltd
ASX:CYC
Total Liabilities & Equity
AU$64.1m
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
23%
Cochlear Ltd
ASX:COH
Total Liabilities & Equity
AU$2.7B
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
13%
Optiscan Imaging Ltd
ASX:OIL
Total Liabilities & Equity
AU$15.6m
CAGR 3-Years
10%
CAGR 5-Years
34%
CAGR 10-Years
34%
EMvision Medical Devices Ltd
ASX:EMV
Total Liabilities & Equity
AU$24m
CAGR 3-Years
31%
CAGR 5-Years
36%
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
47m AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Total Liabilities & Equity amounts to 47m AUD.

What is ImpediMed Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
12%

Over the last year, the Total Liabilities & Equity growth was -32%. The average annual Total Liabilities & Equity growth rates for ImpediMed Ltd have been 11% over the past three years , 16% over the past five years , and 12% over the past ten years .

Back to Top